drugset / Trial / NCT02651519
Sleep Quality After Stellate-ganglion Block of Patients Undergoing Breast Cancer Operation
RandomizedParallel-groupTriple-blindTreatment
Summary
Stellate-ganglion block have been done safely for more than 60 years. It has proved to provide survivors of breast cancer with relief from hot flushes and sleep dysfunction with few or no side-effects. The aim of the present study is to evaluate postoperative sleep quality of patients undergoing breast cancer surgery with Stellate-ganglion block performed in the operation.
Timeline
- Start
- 2016-01
- Primary completion
- 2016-09
- Completion
- 2016-09
Outcome
Met primary endpoint
paper The duration of sleep was significantly increased by 66.3 min in the ropivacaine-SGB group compared with the saline-SGB group. PMID 29043600 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ropivacaine | Other / unclassified | 0.25 % | — |
Indications
No indication recorded.